Suppr超能文献

激酶抑制剂作为抗癌药物的设计方法。

Methods for Design of Kinase Inhibitors as Anticancer Drugs.

作者信息

Gagic Zarko, Ruzic Dusan, Djokovic Nemanja, Djikic Teodora, Nikolic Katarina

机构信息

Department of Pharmaceutical Chemistry, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.

出版信息

Front Chem. 2020 Jan 8;7:873. doi: 10.3389/fchem.2019.00873. eCollection 2019.

Abstract

Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug candidates. Kinases play an essential role in cell function and therefore are extensively studied targets in drug design and discovery. Kinase inhibitors are clinically very important and widely used antineoplastic drugs. In this review, computational methods used in rational drug design of kinase inhibitors are discussed and compared, considering some representative case studies.

摘要

合理药物设计意味着使用分子建模技术,如药效团建模、分子动力学、虚拟筛选和分子对接,来解释生物分子的活性,确定与药物靶点相互作用的分子决定因素,并设计更有效的候选药物。激酶在细胞功能中起着至关重要的作用,因此是药物设计和发现中广泛研究的靶点。激酶抑制剂是临床上非常重要且广泛使用的抗肿瘤药物。在本综述中,考虑一些代表性案例研究,对激酶抑制剂合理药物设计中使用的计算方法进行了讨论和比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad4/6960140/b6ec27cb3e54/fchem-07-00873-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验